Influence of toileting behavior on the natural course of anterior vaginal wall prolapse

BMC Women's Health

Table 1 Comparison of demographic and preoperative data according to voiding and defecation position

	Group-1 (sitting) (n = 44)	Group-2 (squatting) (n = 31)	p
Age (year) (mean ± SD)	57.84 ± 9.19	58.29 ± 9.07	0.835^a
BMI (kg/m²) (mean ± SD)	29.17 ± 3.28	29.67 ± 2.98	0.505^a
Parity (n) (median) (min–max)	3 (1–5)	3 (2–8)	0.221^b
VAS score (median) (min–max)	2 (0–7)	5 (0–10)	< 0.001^b*
Pad count (n) (median) (min–max)	2 (0–6)	2 (0–6)	0.731^b
Menopause duration (month) (median) (min–max)	125 (1–360)	120 (5–300)	0.475^b
Time to surgery (month) (median) (min–max)	24 (2–182)	12 (3–73)	0.001^b*
Topical estrogen use, yes (n) (%)	4 (9.1)	6 (19.4)	0.173^c
Comorbidities (n) (%)
DM	11 (25)	6 (19.24)	0.565^d
HT	22 (50)	17 (54.80)	0.680^d
CAD	2 (4.5)	1 (3.2)	0.630^c
CHF	0 (0)	2 (6.5)	0.168^c
COPD	1 (2.3)	2 (6.5)	0.370^c
Menopause, yes (n) (%)	34 (77.3)	27 (87.1)	0.282^d
Smoking, yes (n) (%)	5 (11.4)	7 (22.6)	0.162^c
Symptoms, yes (n) (%)
Vaginal bulging	37 (84.1)	30 (96.8)	0.081^c
Urgency	19 (43.2)	18 (58.1)	0.204^d
Incontinence	26 (59.1)	21 (67.7)	0.446^d
Splinting or digitation for urination	10 (23.3)	4 (12.9)	0.262^d
POP-Q grade (n) (%)
2	23 (52.3)	14 (45.2)	0.544^d
3	21 (47.7)	17 (54.8)

BMI: Body mass index, CAD: Coronary Artery Disease, CHF: Congestive Heart Failure, COPD: Chronic Obstructive Pulmonary Disease, CRAIQ: Colorectal-Anal Impact Questionnaire, DM: Diabetes Mellitus, HT: Hypertension, PFIQ: Pelvic Floor Impact Questionnaire, POP-Q: Pelvic Organ Prolapse Quantification, POPIQ: Pelvic Organ Prolapse Impact Questionnaire, SD: Standard deviation, UIQ: Urinary Impact Questionnaire, *: statistically significant
^aIndependent sample t test
^bMann–Whitney U test
^cFisher’s exact test
^dChi-square test

ISSN: 1472-6874